azathioprine has been researched along with Kidney Tubular Necrosis, Acute in 21 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Kidney Tubular Necrosis, Acute: Acute kidney failure resulting from destruction of EPITHELIAL CELLS of the KIDNEY TUBULES. It is commonly attributed to exposure to toxic agents or renal ISCHEMIA following severe TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Recipients of first cadaveric kidney allografts were treated with tacrolimus+mycophenolate mofetil (MMF), cyclosporine oral solution (modified) (CsA)+MMF, or tacrolimus+azathioprine (AZA)." | 9.09 | Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M, 2001) |
| " Recipients of first cadaveric kidney allografts were treated with tacrolimus+mycophenolate mofetil (MMF), cyclosporine oral solution (modified) (CsA)+MMF, or tacrolimus+azathioprine (AZA)." | 5.09 | Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. ( Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manrique, J | 1 |
| Rossich, E | 1 |
| Hernández Sierra, A | 1 |
| Light, JA | 1 |
| Biggers, JA | 1 |
| Alijani, MR | 1 |
| Smith, M | 1 |
| Oddendino, K | 1 |
| Flechner, SM | 1 |
| Payne, WD | 4 |
| Van Buren, C | 1 |
| Kerman, R | 1 |
| Kahan, BD | 1 |
| Sutherland, DE | 4 |
| Strand, M | 2 |
| Fryd, DS | 3 |
| Ferguson, RM | 2 |
| Simmons, RL | 3 |
| Ascher, NL | 3 |
| Najarian, JS | 4 |
| Malfi, B | 1 |
| Picciotto, G | 1 |
| Manzione, A | 1 |
| Turello, E | 1 |
| Squiccimarro, G | 1 |
| Messina, M | 1 |
| Segoloni, GP | 1 |
| Troppmann, C | 1 |
| Almond, PS | 1 |
| Dunn, DL | 1 |
| Gores, PF | 1 |
| Gruessner, RW | 1 |
| Matas, AJ | 1 |
| Niaudet, P | 1 |
| Jean, G | 1 |
| Broyer, M | 1 |
| Chatenoud, L | 1 |
| Kitabayashi, K | 1 |
| Munn, SR | 1 |
| Sterioff, S | 1 |
| Ritz, M | 1 |
| Pascoe, MD | 1 |
| Pontin, AR | 1 |
| Kahn, D | 1 |
| Jang, HJ | 1 |
| Kim, SC | 1 |
| Han, DJ | 1 |
| Ahsan, N | 1 |
| Johnson, C | 1 |
| Gonwa, T | 1 |
| Halloran, P | 1 |
| Stegall, M | 1 |
| Hardy, M | 1 |
| Metzger, R | 1 |
| Shield , C | 1 |
| Rocher, L | 1 |
| Scandling, J | 1 |
| Sorensen, J | 1 |
| Mulloy, L | 1 |
| Light, J | 1 |
| Corwin, C | 1 |
| Danovitch, G | 1 |
| Wachs, M | 1 |
| VanVeldhuisen, P | 1 |
| Salm, K | 1 |
| Tolzman, D | 1 |
| Fitzsimmons, WE | 1 |
| Hong, CD | 1 |
| Kapoor, BS | 1 |
| First, MR | 1 |
| Pollak, VE | 1 |
| Alexander, JW | 1 |
| el Mouaaouy, A | 1 |
| Mellert, J | 1 |
| Wetzel, T | 1 |
| Hopt, UT | 1 |
| Rasmussen, K | 1 |
| Pedersen, E | 1 |
| Fischer, J | 1 |
| Kirste, G | 1 |
| Keller, H | 1 |
| Wilms, H | 1 |
| Gonwa, TA | 1 |
| Nghiem, DD | 1 |
| Schulak, JA | 1 |
| Corry, RJ | 1 |
| Sollinger, HW | 1 |
| Deierhoi, M | 1 |
| Kalayoglu, M | 1 |
| Belzer, FO | 1 |
| Canafax, DM | 2 |
| Strand, MH | 1 |
| Sommer, BG | 1 |
| Milford, EL | 1 |
| Kirkman, RL | 1 |
| Tilney, NL | 1 |
| Strom, TB | 1 |
| Carpenter, CB | 1 |
8 trials available for azathioprine and Kidney Tubular Necrosis, Acute
| Article | Year |
|---|---|
Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Clinical Trials as Topic; Cyclosporins; Graft Rejection; Graft S | 1984 |
Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Child; Creatinine; Cyclosporine; Female | 1996 |
Is cyclosporine toxic to the transplanted kidney with acute tubular necrosis?
Topics: Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Hum | 1998 |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
Topics: Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studi | 2000 |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Topics: Administration, Oral; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; | 2001 |
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Aspartate Aminotransferases; Azathioprine; Clinical Trials | 1985 |
Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Clinical Trials as Topi | 1985 |
Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
Topics: Adult; Azathioprine; Cadaver; Clinical Trials as Topic; Cost-Benefit Analysis; Creatinine; Cyclospor | 1985 |
13 other studies available for azathioprine and Kidney Tubular Necrosis, Acute
| Article | Year |
|---|---|
[Multiple complications after renal transplantation].
Topics: Adult; Azathioprine; Cataract; Cholecystitis; Choledocholithiasis; Cyclosporine; Femur Head Necrosis | 2004 |
Serum beta-2-microglobulin: an adjunctive monitoring test in renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; beta 2-Microglobulin; Beta-Globulins; Creatinine; Graft Rejectio | 1980 |
The effect of cyclosporine on early graft function in human renal transplantation.
Topics: Acute Kidney Injury; Azathioprine; Cyclosporins; Graft Survival; Humans; Kidney; Kidney Transplantat | 1983 |
[99mTc-DTPA scintigraphy in renal transplantation. Limitations related to the immunosuppressor used].
Topics: Azathioprine; Cyclosporine; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Kidney | 1993 |
Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Follow-Up Studies; Graft Reject | 1993 |
Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients.
Topics: Adolescent; Antibodies, Anti-Idiotypic; Azathioprine; CD3 Complex; Child; Child, Preschool; Enzyme-L | 1993 |
Fractional excretion of sodium after renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Graft Rejection; Humans; Kidney; Kidney Transplantation; Kidney | 1979 |
Value of sonography for follow-up examination after allogenic kidney transplantation.
Topics: Azathioprine; Cyclosporins; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Trans | 1991 |
Doppler ultrasound in the diagnosis of renal allograft rejection and in monitoring the effect of treatment.
Topics: Azathioprine; Blood Flow Velocity; Cyclosporins; Graft Rejection; Humans; Kidney; Kidney Transplanta | 1990 |
Does ATN influence renal transplant function negatively?
Topics: Acute Kidney Injury; Azathioprine; Cyclosporins; Graft Survival; Humans; Ischemia; Kidney; Kidney Fu | 1988 |
Cyclosporine use in early graft dysfunction.
Topics: Azathioprine; Cadaver; Creatinine; Cyclosporins; Graft Survival; Humans; Kidney; Kidney Transplantat | 1986 |
Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Therapy, Combination; Graft Rejectio | 1986 |
Cyclosporine in renal transplantation: a single institutional experience.
Topics: Azathioprine; Blood Pressure; Cadaver; Cost-Benefit Analysis; Cyclosporins; Drug Evaluation; Follow- | 1985 |